RxDoctor Payments Data

Ahmad Al Turk, MD

Interventional Cardiology · Springfield, ILNPI 1841675725

Payments from drug & device makers

$24,197in general payments, 2019–2025

Across 81 payments — averaging $298.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$15K
  • Edwards Lifesciences$4K
  • Abbott$2K
  • Philips North America LLC$1K
  • Abiomed$741
  • Boston Scientific$424
  • plus $190 from 4 others
$645in research payments, 2019–2025

Across 4 payments — averaging $161.21 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Abiomed$645

What the payments were for

  • Grants$15,00062%
  • Travel & lodging$6,05925%
  • Food & beverage$3,13813%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$24,197 in reported general payments places this provider in the 70th percentile of 303 interventional cardiology providers in Illinois.

See all interventional cardiology providers in Illinois

Medicare billing

Part B allowed, 2024
$101,660
Medicare patients
519
Services billed
1,128

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban31$36,848
EntrestoSacubitril/Valsartan17$13,701
JardianceEmpagliflozin15$13,576
Metoprolol Succinate58$660
Atorvastatin Calcium38$494
Midodrine Hcl11$338
Amlodipine Besylate46$278
Furosemide60$244
Lisinopril31$186
Rosuvastatin Calcium11$180
Isosorbide Mononitrate ErIsosorbide Mononitrate20$176
Losartan Potassium21$121
ClopidogrelClopidogrel Bisulfate25$100
Hydralazine Hcl11$71
Carvedilol18$62

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Springfield

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →